Blog: Zantac - Page 3

When Zantac and other ranitidine medications were discovered to contain harmful levels of the cancer-inducing chemical N-nitrosodimethylamine (NDMA), they were subsequently recalled by the U.S. Food and Drug Administration (FDA) on April 1st, 2020.  However, this recall is a little bit different from others for two reasons: 1) the drug has been in circulation for …

N-nitrosodimethylamine, or NDMA, is a naturally-occurring chemical that can become carcinogenic if repeatedly ingested in large amounts. In recent years, the chemical has been discovered in various prescription medications, most notably in the antacid drug Zantac.  NDMA is actually all around us– the FDA has established a safe intake limit of 96 nanograms per day. …

Zantac and other ranitidine-based drugs were recalled by the US Food and Drug Administration (FDA) on April 1st, 2020 because of their connection to the carcinogenic chemical known as NDMA. Longtime users have been diagnosed with various forms of cancer all throughout the body. As a result, tens of thousands of Zantac users throughout the …

All across the US, tens of thousands of former Zantac users are proceeding with legal action after being diagnosed with cancer as a result of overexposure to NDMA, a carcinogenic chemical that has been discovered in the drug.  As a result, existing and potential plaintiffs have been asking, just what is the expected value of …

Zantac and ranitidine products have been discovered to contain hazardous levels of N-nitrosodimethylamine (NDMA), a documented carcinogen. Longtime users have begun to experience serious complications, such as cancer of the stomach, lungs, liver, and more.  As a result, cancer lawsuits are continuing to pour in by the thousands all across the country. Unsurprisingly, the various …

What is Zantac? Zantac, a Ranitidine product, belongs to a class of drugs called histamine H2-receptor antagonists (also referred to as H2 blockers). H2 blockers decrease the amount of stomach acid produced. Zantac was the first drug to generate $1 billion in sales.  It commonly used to treat the following symptoms: Heartburn Stomach Ulcers GERD …

On April 1st, 2020, the U.S. Food and Drug Administration (FDA) announced that it was ordering manufacturers to withdraw all Zantac and generic over-the-counter ranitidine medications from the market immediately.  The statement released by the administration asserted that the levels of the carcinogenic chemical N-Nitrosodimethylamine (NDMA) in Zantac and other ranitidine medications “increases over time …